Mechanisms and therapeutic targeting of NT5C2 mutations in relapsed acute lymphoblastic leukemiaChelsea L. DieckOpen MINDDecember 19, 201810.7916/d8-y5g9-9573Cited by 1SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis